Hyaluronan-binding peptide can inhibit tumor growth by interacting with Bcl-2

International Journal of Cancer

Volumn 109, Issue 1, 2004, Pages 49-57

  Liu, Ninfei ^a,b   Xu, Xue Ming ^a,c   Chen, Jinguo ^a   Wang, Luping ^a   Yang, Shanmin ^a   Underhill, Charles B ^a   Zhang, Lurong ^a  

^a GEORGETOWN UNIVERSITY MEDICAL CENTER   (United States)

^b SHANGHAI JIAO TONG UNIVERSITY SCHOOL OF MEDICINE   (China)

^c NATIONAL CANCER INSTITUTE   (United States)

Author keywords

Angiogenesis; Apoptosis; Caspases; Cytochrome c; Mitochondria

Indexed keywords

CASPASE; CYTOCHROME C; ENZYME INHIBITOR; HERMES ANTIGEN; HYALURONAN BINDING PEPTIDE; HYALURONIC ACID; P4 PEPTIDE; PEPTIDE; PROTEIN BCL 2; PROTEIN BCL X; PROTEIN BCL XL; SYNTHETIC PEPTIDE; TRITIUM; UNCLASSIFIED DRUG; VASCULOTROPIN;

ANGIOGENESIS; ANIMAL; ANIMAL CELL; ANTINEOPLASTIC ACTIVITY; APOPTOSIS; ARTICLE; BINDING AFFINITY; CANCER CELL CULTURE; CELL DIVISION; CELL LINE; CELL PROLIFERATION; CELL STRAIN 3T3; CELL STRAIN COS1; CHEMISTRY; CHICK EMBRYO; CONFOCAL MICROSCOPY; CONTROLLED STUDY; DOSE RESPONSE; ENZYME LINKED IMMUNOSORBENT ASSAY; FLOW CYTOMETRY; GENE VECTOR; GENETIC TRANSFECTION; GROWTH INHIBITION; HUMAN; HUMAN CELL; IMMUNOPRECIPITATION; METABOLISM; MITOCHONDRION; MOUSE; NEOPLASM; NEOVASCULARIZATION (PATHOLOGY); NONHUMAN; NUDE MOUSE; PEPTIDE SYNTHESIS; PHYSIOLOGY; PRIORITY JOURNAL; PROTEIN BINDING; PROTEIN MOTIF; RAT; SERODIAGNOSIS; TISSUE CULTURE; TUMOR CELL LINE; TUMOR GROWTH; WESTERN BLOTTING;

AMINO ACID MOTIFS; ANIMALS; ANTIGENS, CD44; APOPTOSIS; BCL-X PROTEIN; BLOTTING, WESTERN; CELL DIVISION; CELL LINE; CELL LINE, TUMOR; CHICK EMBRYO; COS CELLS; CULTURE TECHNIQUES; CYTOCHROMES C; DOSE-RESPONSE RELATIONSHIP, DRUG; ENZYME INHIBITORS; ENZYME-LINKED IMMUNOSORBENT ASSAY; FLOW CYTOMETRY; GENETIC VECTORS; HUMANS; HYALURONIC ACID; MICE; MICE, NUDE; MICROSCOPY, CONFOCAL; MITOCHONDRIA; NEOPLASMS; NEOVASCULARIZATION, PATHOLOGIC; NIH 3T3 CELLS; PEPTIDES; PRECIPITIN TESTS; PROTEIN BINDING; PROTO-ONCOGENE PROTEINS C-BCL-2; TRANSFECTION;

EID: 0742287882     PISSN: 00207136     EISSN: None     Source Type: Journal    
DOI: 10.1002/ijc.11636     Document Type: Article

References (32)

1. Liu N, Lapcevich RK, Underhill CB, Han Z, Gao G, Swartz G, Plumb SM, Zhang L, Green SJ. Metastatin: a hyaluronan binding complex for cartilage that inhibits tumor growth. Cancer Res 2001;61:1022-8.
2. Sy MS, Guo YJ, Stamenkovic I. Inhibition of tumor growth in vivo with a soluble CD44-immunoglobulin fusion protein. J Exp Med 1992;176:623-7.
3. Yu Q, Toole BP, Stamenkov I. Induction of apoptosis of metastatic mammary carcinoma cells in vivo by disruption of tumor cell surface CD44 function. J Exp Med 1997;186:1985-96.
4. Mohapatra S, Yang X, Wright JA, Turley EA, Greenberg AH. Soluble hyaluronan receptor RHAMM induces mitotic arrest by suppressing Cdc2 and cyclin B1 expression. J Exp Med 1996;183:1663-8.
5. Wisniewski HG, Hua J-C, Poppers DM, Naime D, Vilcek J, Cronstein BN. TSG-6, a glycoprotein associated with arthritis, and its ligand hyaluronan exert opposite effects in a murine model of inflammation. J Immunol 1996;156:1609-15.
6. O'Reilly MS, Boehm T, Shing Y, Fuka N, Wasios G, Lane WS, Flynn E, Birkhead JR, Olsen BR, Folkman J. Endostatin: an endogenous inhibitor of angiogenesis and tumor growth. Cell 1997;88:277-85.
7. Hohenester E, Sasaki T, Olsen BR, Timpl R. Crystal structure of the angiogenesis inhibitor endostatin at 1.5 A resolution. EMBO J 1998; 17:1656-64.
8. Yang B, Yang BL, Savani RC, Turley EA. Identification of a common hyaluronan binding motif in the hyaluronan binding proteins RHAMM, CD44 and link protein. EMBO J 1994;13:286-96.
9. Yang B, Zhang L, Turley EA. Identification of two hyaluronan-binding domains in the hyaluronan receptor RHAMM. J Biol Chem 1993;268:8617-23.
10. Hope TJ, Zhu L, Parslow TG, Yang B, Stern M, Turley EA, Stern R. Partial sequence of porcine liver hyaluronidase: identification of a hemoplexin and two putative HA-binding domains. J Cell Biochem Suppl 1993;17E:175 (abstract).
11. Goetinck PF, Stirpe NS, Tsonis PA, Carlone D. The tandemly repeated sequences of cartilage link protein contain the sites for interaction with hyaluronic acid. J Cell Biol 1987;105:2403-08.
12. Banerji S, Ni J, Wang SX, Clasper S, Su J, Tammi R, Jones M, Jackson DG. LYVE-1, a new homologue of the CD44 glycoprotein, is a lymph-specific receptor for hyaluronan. J Cell Biol 1999;144:789-801.
13. Saarela J, Ylikarppa R, Rehn M, Purmonen S, Pihlajaniemi T. Complete primary structure of two variant forms of human type XVIII collagen and tissue-specific differences in the expression of the corresponding transcripts. Matrix Biol 1998;16:319-28.
14. Arap W, Pasqualini R, Ruoslahti E. Cancer treatment by targeted drug delivery to tumor vasculature in a mouse model. Science 1998;279:377-80.
15. Culty M, Shizari M, Thompson EW, Underhill CB. Binding and degradation of hyaluronan by human breast cancer cell lines expressing different forms of CD44: correlation with invasive potential. J Cell Phys 1994;160:275-86.
16. Brooks PC, Silletti S, von Schalscha TL, Friedlander M, Cheresh DA. Disruption of angiogenesis by PEX, a noncatalytic metalloproteinase fragment with integrin binding activity. Cell 1998;92:391-400.
17. Cossarizza A, Kalashnikova G, Grassilli E, Chiapelli R, Salvioli S, Capri M, Barbieri D, Troiano L, Rfanceschi C. Mitochondrial modification during rat thymocyte apoptosis: a study at the single cell level. Exp Cell Res 1994;214:23-330.
18. Vermes I, Haanen C, Steffens-Nakken H, Reutelingsperger C. A novel assay of apoptosis: flow cytometric detection of phosphatidylserine expression on early apoptotic cells using fluorescein labelled Annexin V. J Immunol Meth 1995;184:39-51.
19. Pedersen PL, Greenawalt JW, Reynafarje B, Hullihen J, Decker GL, Soper JW, Bustamente E. Preparation and characterization of mitochondria and submitochondrial particles of rat liver and liver-derived tissues. Meth Cell Biol 1978;20:411-81.
20. Green DR, Reed JC. Mitochondria and apoptosis. Science 1998;281:1309-12.
21. McColl KS, He H, Xhong H, Whitacre CM, Berger NA, Distelhorst CW. Apoptosis induction by the glucocorticoid hormone dexamethasone and the calcium-ATPase inhibitor thapsigargin involves Bcl-2 regulated caspase activation. Molec Cell Endocrinol 1998;139:229-38.
22. Adams JM, Cory S. The Bcl-2 protein family: arbiters of cell survival. Science 1998;181:1322-26.
23. Matuoka K, Namba M, Mitsui Y. Hyaluronate synthetase inhibition by normal and transformed human fibroblasts during growth reduction. J Cell Biol 1987;104:1105-15.
24. Mohamadzadeh M, DeGrendele H, Arizpe H, Estess P, Siegelman M. Proinflammatory stimuli regulate endothelial hyaluronan expression and CD44/HA-dependent primary adhesion. J Clin Invest 1998;101:97-108.
25. Culty M, Nguyen NA, Underhill CB. The hyaluronan receptor (CD44) participates in the uptake and degradation of hyaluronan. J Cell Biol 1992;116:1055-62.
26. Kovacsovics-Bankowski M, Rock KL. A phagosome-to-cytosol pathway for exogenous antigens presented on MHC class I molecules. Science 1995;267:243-6.
27. Browder T, Butterfield CE, Kraling NM, Blair NS, O'Reilly MS, Folkman J. Antiangiogenic scheduling of chemotherapy improves efficacy against experimental drug-resistant cancer. Cancer Res 2000; 60:1878-86.
28. L-Bak peptide complex: recognition between regulators of apoptosis. Science 1997;275:983-6.
29. Wang JL, Zhang ZJ, Choksi S, Shan S, Lu Z, Croce CM, Alnemri ES, Komgold R, Huang Z. Cell permeable Bcl-2 binding peptides: a chemical approach to apoptosis induction in tumor cells. Cancer Res 2000;60:1498-502.
30. Mummert ME, Mohamadzadeh M, Mummert SI, Mizumoto N, Takashima A. Development of a peptide inhibitor of hyaluronan-mediated leukocyte trafficking. J Exp Med 2000;192:769-79.
31. Ellerby HM, Apap W, Ellerby LM, Kain R, Andrusiak R, Rio GD, Krajewski S, Lombardo CR, Rao R, Ruoslahti E, Bredesen DE, Pasqualini R. Anti-cancer activity of targeted pro-apoptotic peptides. Nat Med 1999;5:1032-38.
32. Chen, Y, Xu X, Chen JN, Underhill CB, Creswell K, Hong S, Zhang L. Anti-tumor effects of RGD-tachyplesin. Cancer Res. 2001;61:2434-38.